RECRUITINGOBSERVATIONAL
Study of the Progression of Chronic Cardiovascular Conditions
A Non-interventional Observational Study of the Sustained Use of Prolaio Digital Health Devices to Monitor the Natural History of Chronic Cardiovascular Conditions in Ambulatory Patients
About This Trial
This study will collect physiologic data in patients with cardiovascular conditions and observe the natural history of those conditions for research purposes.
Who May Be Eligible (Plain English)
Who May Qualify:
- 18 years of age and older
- Ability to understand study assessments and give willing to sign a consent form to data collection
- Ability to comply with the study protocol
- Ability to understand and respond to instructions in English
- Has diagnosis of qualifying Cardiovascular Disease(s) (CVD) including but not limited to: HF, AS, HCM, HTN, DCM, etc.
- Resides in the United States
Who Should NOT Join This Trial:
- Allergy to adhesive used in biosensor patch
- Life threatening disease process outside of area under study, such as actively treated cancer or pre/post-transplant such as hepatic failure; end-stage renal disease.
- Severe CVD defined by hospital admission for cardiac diagnosis within 30 days of enrollment or documentation of NYHA functional class IV
- Self-reported weight of 400 pounds or greater
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* 18 years of age and older
* Ability to understand study assessments and give informed consent to data collection
* Ability to comply with the study protocol
* Ability to understand and respond to instructions in English
* Has diagnosis of qualifying Cardiovascular Disease(s) (CVD) including but not limited to: HF, AS, HCM, HTN, DCM, etc.
* Resides in the United States
Exclusion Criteria:
* Allergy to adhesive used in biosensor patch
* Life threatening disease process outside of area under study, such as actively treated cancer or pre/post-transplant such as hepatic failure; end-stage renal disease.
* Severe CVD defined by hospital admission for cardiac diagnosis within 30 days of enrollment or documentation of NYHA functional class IV
* Self-reported weight of 400 pounds or greater
Locations (1)
Prolaio
Chicago, Illinois, United States